ClinicalTrials.Veeva

Menu

Use of Alkasite for Postpulpotomy Restoration (Cention-Forte)

T

Tanta University

Status

Active, not recruiting

Conditions

Post Pulpotomy Restoration
Pediatric Dentistry

Treatments

Procedure: Cention Forte
Procedure: Tetric® N-Ceram

Study type

Interventional

Funder types

Other

Identifiers

NCT07355920
#P-PED-6-24-2204

Details and patient eligibility

About

The aim of this study will be directed to:

Evaluate the clinical performance of alkasite composite as a final restoration for pulpotomized primary molars.

Enrollment

25 patients

Sex

All

Ages

4 to 8 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Deep carious vital primary molars at site 1, 2, and size 3 according to the SI/STA classification of caries.
  • Healthy children free from systemic diseases.
  • Cooperative patient: Frankel rating 3,4.

Radiographically:

  • Deep caries approximating the pulp.
  • Roots with no more than one-third physiologic resorption.
  • Normal lamina dura and periodontal ligament space.

Exclusion criteria

  • Patients with bruxism.
  • Clinical signs or symptoms of irreversible pulpitis or pulp degeneration.
  • Parents refuse treatment.

Radiographically:

  • Furcation involvement.
  • periapical lesion.
  • Pathologic resorption (internal or external).

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

25 participants in 2 patient groups

Group I: Study group :Alkasite( cention forte )
Experimental group
Description:
25 primary molars were restored with an Alkasite composite Cention-forte after Formocresol pulpotomy.
Treatment:
Procedure: Cention Forte
Group II :Control group: Tetric N-Ceram
Active Comparator group
Description:
25 primary molars were restored with Tetric® N-Ceram bulk-fill composite after Formocresol pulpotomy.
Treatment:
Procedure: Tetric® N-Ceram

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems